Mentions
Extended reach
Total likes
Video views
AI synopsis
The group’s conversations reveal skepticism and disappointment, exemplified by phrases like 'null results' and 'no effect,' as well as dismissals of the supplement's efficacy. Words like 'meh' and 'disappointing' highlight a tone of skepticism and low enthusiasm, showing that the study's findings are seen as undermining previous positive beliefs about nattokinase’s benefits.
The majority of discussions express disappointment or skepticism about the study's findings, indicating strong disagreement with the idea that nattokinase is effective for heart health.
Posts show moderate interest, mainly reacting to the study's results without deeper exploration or curiosity, often dismissing or criticizing the findings.
Many comments reflect superficial reactions or dismissive attitudes, with few engaging in detailed analysis of the methodology or implications.
Overall, the social discussions suggest minimal impact on beliefs or practices, as the consensus appears to be that the research challenges prior claims and leaves little room for influence.
1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significantly impact the progression of subclinical atherosclerosis (https://t.co/QnRPr0nolE.)
However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect on blood coagulation and fibrinolysis factors, blood pressure or any other tested labs, & didn't decrease https://t.co/mmDq0h4l58 https://t.co/nPNzB6Clpn
Nattokinase atherothrombotic prevention study: A randomized controlled trial https://t.co/onigGsKWAW
Because a prominent anti-vaxxer is now hawking nattokinase to something something vaccine blood etc, now is a good time to share the first clinical trial on this supplement. Spoiler: no effect. https://t.co/WdLmyy56Vv
@barriere_dr Je ne comprends pas comment on peut croire qu’un enzyme, qui est une proteine, puisse sans dégradation, passer la barrière du tube digestif (estomac, intestin, foie) pour ensuite aller dégrader une autre protéine (spike) dans le sang. Pour les sceptiques:https://t.co/VVtU8dSgsN
@wideawake_media Hodis2021: at no time point, incl. early time points of 1 wk+1,3&6m post-randomization, did nattokinase suppl. have a detectable treatment effect on any coagulation factor, fibrinolytic factor or platelet aggregation rel. to placebo https://t.co/7wz5kH3Avl https://t.co/hIgVz4oBC0
The study found that consuming nattokinase, a fermented soy extract, can reduce blood pressure in hypertensive individuals, especially in males, and decrease cardiovascular risk markers like von Willebrand factor…
This study tested whether nattokinase, a supplement thought to benefit heart health, actually slows down the development of early atherosclerosis and improves related blood markers. Over about 3 years, participants…
@dtraderaus @The_Healthy_Man @NutritionTipzzz https://t.co/SNf1miUVjQ
@jwmares It sounded too lovely for a final solution
RT @mike_lustgarten: Nattokinase atherothrombotic prevention study: A randomized controlled trial https://t.co/onigGsKWAW
Nattokinase atherothrombotic prevention study: A randomized controlled trial https://t.co/onigGsKWAW
RT @DrPaulMason: 1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significan…
RT @DrPaulMason: 1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significan…
RT @DrPaulMason: 1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significan…
RT @DrPaulMason: 1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significan…
1. Lower Doses Ineffective for Atherosclerosis A study found that lower doses of nattokinase (2,000 FU) did not significantly impact the progression of subclinical atherosclerosis (https://t.co/QnRPr0nolE.)
@EchoplexSE @Cernovich https://t.co/rBZWNJStSb lol “some studies” means studies by the people who sell it. Real studies say it’s meh
Mixed evidence of Nattokinase on blood pressure. Positive (8-week study): https://t.co/g95QEBKe00 Neutral (3 years): https://t.co/uYyxprGDH7 Both used the same dose: 2000 fibrinolytic units/d
ナットウキナーゼの大規模かつ長期的な心血管系研究を実施 265名の経口ナットウキナーゼ 2千線溶単位投与のRCTを実施,主要評価は,頸動脈内膜中膜肥厚及び頸動脈硬化とし,6 か月毎に動脈硬化の変化率を測定3年間の観察でナットウキナーゼ補給群とプラセボ群で有意差は無ったhttps://t.co/gbEceWoLXi
@LDLSkeptic Hodis HN, Mack WJ. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clin Hemorheol Microcirc. 2021;78(4):339-353. doi: 10.3233/CH-211147. PMID: 33843667.
@biohacker An RCT showed null results at 2000 u/day https://t.co/xom8PrHSfv
@minamiyoro @UfOrUBZo4T3HcWq @Jimo0404 @q6Aci2K8Jc32740 @KEIZOmini3298 @MCTM524457 @KDMCYcpefGyBUq7 @Kuroi_Yahu @rnHZo8uwzbvtqH5 @gaugaugauta @a7WDZFK5er77036 @PLC_Kei @JESUS2daime @takaku2021 @mcallister11111 @minamiyoroyoro @hide3ttu @tomo_hiko @hime1booo なかったみたい https://t.co/jQn8dJusFr
@eagihado @alxd1224 @yC8DsJFnhv78913 ちなみに長期投与のRCTを見つけました。 Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical Hemorheology and Microcirculati...(IOS Press) - Vol. 78, Iss: 4, pp 339-353 ここでは、長期投与で凝固線溶系で有意差がなく、意味がないって結論です。
A 2017 clinical trial in China found that a dose of 6,000 FU/day was effective https://t.co/znqxFpIoPs But a 2021 clinical trial found that a dose of 2,000 FU/day wasn't effective https://t.co/6ZsFAnZx4X
@TheFrankmanMN @VirusSmThanHole @davideyoungmd @Pouldeau61 @TakethatCt @ShaneAKAProp @thecountof1 @sduncanhealth @bjurrows @AnnLove4All @doritmi @runhack @djt10 @Arkout3 @taurusg333 @cappsie @TonyBaduy @Danny459673 @WendyOrent @raoulduke49 @DaveBla81093404 @crabb_vicki @krebiozen @MsTrixter @Hurriquake @MONTMAN9500 @StuWizzle @Golfergirl2018 @dann58638436 @Scary7Dr @BB0941167867205 @Kathmarval @encyclopath @1_TMF_ @Fornowago @FUDyou2 @Catheri49917567 @RadioColor @tonymac5 @groin_hammer @CyclopsSeesAll @ScienceMonkey0 @Just4TheCause @zendogbreath @FormerAntivax @BruceFo43322941 @DK25769559 @BigBopp75348974 @provaxtexan @MarioMoney23 and...no effect compared to placebo... https://t.co/4Im0tIeTAq
@lucindasan15671 @Truth_in_Number @sharkzfanz Why block me when I hadn’t responded?
RT @sandoly: @wideawake_media Hodis2021: at no time point, incl. early time points of 1 wk+1,3&6m post-randomization, did nattokinase suppl…
RT @sandoly: @wideawake_media Hodis2021: at no time point, incl. early time points of 1 wk+1,3&6m post-randomization, did nattokinase suppl…
@wideawake_media Hodis2021: at no time point, incl. early time points of 1 wk+1,3&6m post-randomization, did nattokinase suppl. have a detectable treatment effect on any coagulation factor, fibrinolytic factor or platelet aggregation rel. to placebo https://t.co/7wz5kH3Avl https://t.co/hIgVz4oBC0
@Sabsi0431 @DrSynthetiks @reitschuster 2000IU haben keinen Effekt auf Arteriosklerose https://t.co/oLVvyG3xoR
@error_dome @BowTiedOx I sure can https://t.co/jCQHdOp21v
@barriere_dr Je ne comprends pas comment on peut croire qu’un enzyme, qui est une proteine, puisse sans dégradation, passer la barrière du tube digestif (estomac, intestin, foie) pour ensuite aller dégrader une autre protéine (spike) dans le sang. Pour les sceptiques:https://t.co/VVtU8dSgsN
Well .. darn .. they RCT’d my latest N=1 (nattokinase) and found no benefit. But, only used 2000FU. Most papers seem to indicate 10000FU. https://t.co/oTr0LTfVwI
Nattokinase RCT- 3 yrs of treatment: “Results of this trial show that nattokinase supplementation has a null effect on subclinical atherosclerosis progression in healthy individuals at low risk for CVD” https://t.co/7qvADqUvoG
RT @drbrignall: Because a prominent anti-vaxxer is now hawking nattokinase to something something vaccine blood etc, now is a good time to…
RT @drbrignall: Because a prominent anti-vaxxer is now hawking nattokinase to something something vaccine blood etc, now is a good time to…
Because a prominent anti-vaxxer is now hawking nattokinase to something something vaccine blood etc, now is a good time to share the first clinical trial on this supplement. Spoiler: no effect. https://t.co/WdLmyy56Vv
@florpodesta5 @useless_priest Large, randomized, controlled clinical trial, no effect for nattokinase. https://t.co/f1YpZyJrRj Proteins are simply not effectively delivered across the gut barrier in healthy persons. If your blood was ‘gellish’ before, see a doctor. But enjoy your placebo effect.
「ナットウキナーゼ意味ない」という論文 https://t.co/KuKk6vFZLy
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
RT @organichemusic: However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect o…
However, this larger RCT from 2021 concluded that after a median 3 yrs, daily 2000 FU NK showed no significant effect on blood coagulation and fibrinolysis factors, blood pressure or any other tested labs, & didn't decrease https://t.co/mmDq0h4l58 https://t.co/nPNzB6Clpn
BUMMER! Nattokinase atherothrombotic prevention study: A randomized controlled trial https://t.co/raqN6CeRgg #kahnchronicle
Nattokinase atherothrombotic prevention study: A randomized controlled trial (null) https://t.co/vWQv57LB7x
Nattokinase atherothrombotic prevention study: A randomized controlled trial https://t.co/Eohc4cIrnW https://t.co/TPIfZqrNc4
doi: 10.3233/CH-211147. Park S, Kim CJ, Ha KC, et al. Efficacy and safety of aronia, red ginseng, shiitake mushroom, and nattokinase mixture on insulin ...
doi: 10.3233/CH-211147 13:1177271918785130. doi: 10.1177/1177271918785130 4. Nagata C, Wada K, Tamura T, Konishi K, Goto Y, Koda S, et al. Dietary soy and ...
http://dx.doi.org/10.3233/CH-211147 PMID: 33843667. Copyright © Chris Masterjohn, 2022. All rights reserved. Not for distribution. Do not store this in the ...
PM
L
MP
MB
KP
SS
EN
M
TL
AP
R
D
DT
JB
WL
み
R
M
じT
後回
SL
RM
IB
A
WA
VV
JC
IC
DL
T
LR
山腸
DM
HP
TI
AK
C
CE
PB
C
JF
A
S